The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary. United States Politics and Government, Regulation and Deregulation of Industry, Appointments and Executive Changes, Government Employees, Drugs (Pharmaceuticals), Rare and Orphan Diseases, Centers for Disease Control and Prevention, Food and Drug Administration, Health and Human Services Department, Kennedy, Robert F Jr, Makary, Marty, Trump, Donald J Read More
F.D.A. Turmoil Keeps Spotlight on Its Commissioner
